Status:
ENROLLING_BY_INVITATION
Supporting Use of AC Through Provider Profiling of Oral AC Therapy for AF IV
Lead Sponsor:
University of Massachusetts, Worcester
Collaborating Sponsors:
University of Florida
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Six million Americans live with atrial fibrillation (AF), a heart rhythm abnormality that is a major risk factor for stroke and only half of those AF patients receive oral anticoagulation (AC). Within...
Detailed Description
The proposed project will examine the impact of a novel anticoagulant (AC) clinical decision support tool within the electronic health record (EHR) on AC prescribing behaviors among healthcare provide...
Eligibility Criteria
Inclusion
- Providers caring for patients aged 18 years and older with international classification of disease 10th revision (ICD-10) diagnostic code consistent with atrial fibrillation (AF) or atrial flutter who had a visit with a primary care provider or cardiovascular medicine specialist in the previous one year with the diagnosis of AF present as an active diagnosis in the electronic health record (EHR).
- Patients aged 18 years and older with ICD-10 diagnostic code consistent with AF or atrial flutter who had a visit with a primary care provider or cardiovascular medicine specialist in the previous one year with the diagnosis of AF present as an active diagnosis in the EHR.
Exclusion
- Left atrial appendage closure
- Hospice status
- Providers who do not care for patients aged 18 years and older with ICD-10 diagnostic code consistent with AF or atrial flutter who had a visit with a primary care provider or cardiovascular medicine specialist in the previous one year with the diagnosis of AF present as an active diagnosis in the EHR.
- Patients under the age of 18; patients without a ICD-10 diagnostic code consistent with AF or atrial flutter who had a visit with a primary care provider or cardiovascular medicine specialist in the previous one year with the diagnosis of AF present as an active diagnosis in the EHR. Patients will also be excluded from this study if they are known to be pregnant or a prisoner.
Key Trial Info
Start Date :
December 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2026
Estimated Enrollment :
5094 Patients enrolled
Trial Details
Trial ID
NCT05236556
Start Date
December 15 2022
End Date
June 30 2026
Last Update
May 18 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Florida College of Medicine - Jacksonville
Jacksonville, Florida, United States, 32209
2
UMass Chan Medical School
Worcester, Massachusetts, United States, 01655